Global Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet and Pa

Global Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats, Others) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) and Regional Forecasts 2022-2032

Global Hemostats Market is valued approximately USD 2.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.76% over the forecast period 2024-2032. Hemostats are surgical tools designed to control bleeding by clamping blood vessels or tissue. They come in various shapes and sizes, but they typically resemble forceps or scissors with locking mechanisms. Hemostats can be made from stainless steel or other materials, and they may have straight or curved jaws. The key trend of Global Hemostats Market is growing focus on minimally invasive surgeries. The minimally invasive surgical techniques have gained popularity due to their benefits, including shorter hospital stays, quicker recovery times, and reduced risk of complications. Hemostats play a crucial role in these procedures by facilitating efficient hemostasis with minimal tissue damage.

Moreover, as the number of surgical procedures rises globally, the demand for hemostatic agents also increases. Hemostats are essential in controlling bleeding during surgeries, thus driving market growth. Also, the aging population is more prone to chronic diseases and conditions that require surgical interventions. This demographic trend fuels the demand for hemostatic products, as older individuals may have more complex medical needs and may require surgeries that involve significant bleeding risk. Additionally, other factors support the market growth are expanding applications in non-surgical settings, and rising healthcare expenditure. However, negative effects and allergic responses associated with hemostats are expected to impede Global Hemostats Market growth during 2024 to 2032.

The key regions considered for the Global Hemostats Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America leads the hemostats industry, commanding the largest market share due to its robust R&D infrastructure and the presence of key industry players. These companies possess substantial expertise, resources, and well-established distribution networks, bolstering the region's market dominance. Additionally, the high prevalence of chronic diseases in North America places significant pressure on healthcare systems, driving the demand for hemostatic products. The region also experiences a surge in various surgical procedures like orthopedic, bariatric, hernia repair, cardiothoracic, and neurological surgeries, further fueling the need for hemostats. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period 2024-2032.

Major market player included in this report are:
Johnson and Johnson
Baxter International Inc.
Integra Life Sciences Holding Corporation
Stryker Corporation
Pfizer Inc.
Becton Dickinson and Company
Medtronic Plc
B.Braun Melsungen AG
Teleflex Incorporated
Hemostatis LLC

The detailed segments and sub-segment of the market are explained below:
By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.